REQUEST A DEMO
Total
USD $0.00
Search more companies

Lenispharm d.o.o. (Croatia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Lenispharm d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lenispharm d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on December 09, 2025. Lenispharm d.o.o. currently employs 14 (2024) people. The company’s latest financial report indicates a net sales revenue increase of 26.01% in 2024. Its’ total assets recorded a growth of 48.34%. The net profit margin of Lenispharm d.o.o. decreased by 2.82% in 2024.

Headquarters
Rim 2 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Lenispharm d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Lenispharm d.o.o. report to view the information.
Financial Auditors:
Purchase the Lenispharm d.o.o. report to view the information.
Incorporation Date:
December 09, 2025
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Lenispharm d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
26.01%
Total operating revenue
26.01%
Operating profit (EBIT)
-45.17%
EBITDA
40.06%
Net Profit (Loss) for the Period
-54.04%
Total assets
48.34%
Total equity
23.63%
Operating Profit Margin (ROS)
-2.86%
Net Profit Margin
-2.82%
Return on Equity (ROE)
-15.91%
Debt to Equity Ratio
39.41%
Quick Ratio
-0.7%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?